Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

In recent years we and others have used the ELISPOT assay successfully to identify novel tumor antigens by the characterization of spontaneous HLA class I restricted immune responses against a number of minimal 9–10 amino acid long peptide epitopes. In the present study, we examined the capability o...

Full description

Bibliographic Details
Main Authors: Mads Hald Andersen, Per Thor Straten, Inge Marie Svane, Morten Hansen, Stine Kiaer Larsen
Format: Article
Language:English
Published: MDPI AG 2012-04-01
Series:Cells
Subjects:
ELISPOT
Bcl-X(L)
long peptides
antigen
T cells
Online Access:http://www.mdpi.com/2073-4409/1/2/51

Internet

http://www.mdpi.com/2073-4409/1/2/51

Similar Items